The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118196153 11819615 3 F 2000 20160804 20151210 20160929 PER US-JNJFOC-20150713739 JANSSEN 0.00 T M Y 0.00000 20160929 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118196153 11819615 1 SS RISPERDAL RISPERIDONE 1 Oral U U 0 2 MG UNSPECIFIED
118196153 11819615 2 SS RISPERDAL RISPERIDONE 1 Oral U U 0 4 MG UNSPECIFIED
118196153 11819615 3 PS RISPERDAL RISPERIDONE 1 Oral U U 20272 UNSPECIFIED
118196153 11819615 4 SS INVEGA PALIPERIDONE 1 Oral U U 0 OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET
118196153 11819615 5 SS INVEGA PALIPERIDONE 1 Oral U U 21999 9 MG OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET
118196153 11819615 6 SS RISPERDAL CONSTA RISPERIDONE 1 Intramuscular U U 0 50 MG MICROSPHERES
118196153 11819615 7 SS RISPERDAL CONSTA RISPERIDONE 1 Intramuscular U U 0 50 MG MICROSPHERES
118196153 11819615 8 SS RISPERDAL CONSTA RISPERIDONE 1 Intramuscular U U 0 50 MG MICROSPHERES
118196153 11819615 9 SS RISPERDAL CONSTA RISPERIDONE 1 Intramuscular U U 21346 50 MG MICROSPHERES
118196153 11819615 10 SS INVEGA SUSTENNA PALIPERIDONE PALMITATE 1 Intramuscular U U 22264 INJECTION
118196153 11819615 11 SS RISPERIDONE. RISPERIDONE 1 Oral U 0 TABLETS
118196153 11819615 12 SS RESPIDON RISPERIDONE 1 Oral U 0 TABLETS
118196153 11819615 13 SS RESPIDON RISPERIDONE 1 Unknown U 0 INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118196153 11819615 1 Attention deficit/hyperactivity disorder
118196153 11819615 2 Attention deficit/hyperactivity disorder
118196153 11819615 3 Attention deficit/hyperactivity disorder
118196153 11819615 4 Attention deficit/hyperactivity disorder
118196153 11819615 5 Attention deficit/hyperactivity disorder
118196153 11819615 6 Attention deficit/hyperactivity disorder
118196153 11819615 7 Attention deficit/hyperactivity disorder
118196153 11819615 8 Attention deficit/hyperactivity disorder
118196153 11819615 9 Attention deficit/hyperactivity disorder
118196153 11819615 10 Product used for unknown indication
118196153 11819615 11 Product used for unknown indication
118196153 11819615 12 Product used for unknown indication
118196153 11819615 13 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
118196153 11819615 Abnormal weight gain
118196153 11819615 Gynaecomastia
118196153 11819615 Off label use
118196153 11819615 Product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118196153 11819615 1 201202 201205 0
118196153 11819615 2 201107 201202 0
118196153 11819615 3 2000 0
118196153 11819615 4 20120228 2012 0
118196153 11819615 5 20110823 2012 0
118196153 11819615 6 201206 201208 0
118196153 11819615 7 201201 201202 0
118196153 11819615 8 201210 201302 0
118196153 11819615 9 201109 0